华泰联合证券有限责任公司 关于湖北华强科技股份有限公司 2024年年报问询函回复的核查意见 上海证券交易所： 一、公司说明 （一）列示报告期集体防护装备主要合同的签订时间、金额、交易内容、发 货时间以及收入确认时点，量化分析本期集体防护装备收入大幅增长、毛利率由 负转正的原因，并结合在手订单及合同负债情况，说明是否具有可持续性 1、列示报告期集体防护装备主要合同的签订时间、金额、交易内容、发货 时间以及收入确认时点，量化分析本期集体防护装备收入大幅增长、毛利率由负 转正的原因 根据贵所《关于对湖北华强科技股份有限公司 2024 年年度报告的信息披露 监管问询函》（上证科创公函【2025】0268 号，以下简称"问询函"）的要求， 华泰联合证券有限责任公司（以下简称"华泰联合证券"或"持续督导机构"） 作为湖北华强科技股份有限公司（以下简称"华强科技"或"公司"）的持续督 导机构，会同公司及相关中介机构，对问询函所提及的事项进行了逐项落实，现 将问询函所涉及问题回复如下： 1、关于主营业务 年报显示，公司实现营业收入 6.11 亿元，同比增长 6.74%，实现归母净利 润 2,252.79 万元，同比增长 18 ...

Group 1 - The core viewpoint of the news is that the military equipment restructuring concept has seen a decline of 3.20%, ranking among the top declines in the concept sector, with companies like Changcheng Military Industry, Hunan Tianyan, and Huqiang Technology experiencing significant drops [1][2]. - The military equipment restructuring concept sector experienced a net outflow of 429 million yuan in capital today, with seven stocks seeing net outflows exceeding 10 million yuan [2]. - The stock with the highest net outflow is Changcheng Military Industry, which saw a net outflow of 147 million yuan, followed by Hunan Tianyan and Zhongguang Optical with net outflows of 111 million yuan and 49.57 million yuan, respectively [2]. Group 2 - The top decliners in the military equipment restructuring concept include Changcheng Military Industry with a decline of 6.23%, Hunan Tianyan with a decline of 5.57%, and Huqiang Technology with a decline of 4.34% [2]. - The trading turnover rate for Changcheng Military Industry was 11.07%, while Hunan Tianyan had a turnover rate of 19.94% [2]. - Other companies in the outflow list include Chang'an Automobile, which saw a slight decline of 0.16% with a net outflow of 46.81 million yuan, and Construction Industry with a decline of 2.04% and a net outflow of 25.62 million yuan [2].

Group 1 - The board of directors of Hubei Huqiang Technology Co., Ltd. held its 12th meeting of the second session on July 8, 2025, with all 9 directors present, ensuring compliance with relevant laws and regulations [1][2] - The board approved the proposal to change the continuous supervision sponsor institution and sponsor representative, authorizing the management to handle related matters [1][2] - The board also approved the proposal to re-sign the tripartite supervision agreement for raised funds after changing the sponsor institution, granting management the authority to sign the agreement with the sponsor institution and the bank [2]

证券代码：688151 证券简称：华强科技 公告编号：2025-030 湖北华强科技股份有限公司 关于变更持续督导保荐机构及保荐代表人 的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 经中国证券监督管理委员会《关于同意湖北华强科技股份有限公司首次公开 发行股票注册的批复》（证监许可20213368 号）同意注册，并经上海证券交易 所同意，湖北华强科技股份有限公司（以下简称"公司"）于 2021 年 12 月 6 日在上海证券交易所科创板上市。公司聘请了华泰联合证券有限责任公司（以下 简称"华泰联合证券"）担任公司首次公开发行股票并在科创板上市的保荐机构， 华泰联合证券对公司的持续督导期至 2024 年 12 月 31 日。因前述期限届满后公 司募集资金尚未使用完毕，华泰联合证券对未使用完毕的募集资金使用情况继续 履行持续督导义务。 经与各方友好协商一致，公司于 2025 年 7 月 8 日召开的第二届董事会第十 二次会议审议通过了《关于变更持续督导保荐机构和保荐代表人的议案》《关于 变更保荐机构后重新签订募集资金三 ...

经中国证券监督管理委员会《关于同意湖北华强科技股份有限公司首次公开 发行股票注册的批复》（证监许可[2021]3368 号）同意注册，并经上海证券交易 所同意，湖北华强科技股份有限公司（以下简称"公司"）于 2021 年 12 月 6 日在上海证券交易所科创板上市。公司聘请了华泰联合证券有限责任公司（以下 简称"华泰联合证券"）担任公司首次公开发行股票并在科创板上市的保荐机构， 华泰联合证券对公司的持续督导期至 2024 年 12 月 31 日。因前述期限届满后公 司募集资金尚未使用完毕，华泰联合证券对未使用完毕的募集资金使用情况继续 履行持续督导义务。 经与各方友好协商一致，公司于 2025 年 7 月 8 日召开的第二届董事会第十 二次会议审议通过了《关于变更持续督导保荐机构和保荐代表人的议案》《关于 变更保荐机构后重新签订募集资金三方监管协议的议案》，同意公司持续督导保 荐机构由华泰联合证券变更为长江证券承销保荐有限公司（以下简称"长江保 荐"），并重新签订募集资金三方监管协议，同时董事会授权公司管理层办理持 续督导协议、募集资金三方监管协议签署等相关事宜。 公司将与长江保荐签订《持续督导协议》，长江保 ...

证券代码：688151 证券简称：华强科技 公告编号：2025-031 湖北华强科技股份有限公司 第二届董事会第十二次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 湖北华强科技股份有限公司（以下简称"公司"）于 2025 年 7 月 8 日以现场 结合视频会议的方式在公司会议室召开第二届董事会第十二次会议。本次会议的 通知于 2025 年 7 月 3 日通过电子邮件方式送达全体董事。本次会议由董事长孙 光幸先生主持，应出席董事 9 名，实际出席董事 9 名，公司监事、高级管理人员 列席了会议。本次会议的召集和召开符合《中华人民共和国公司法》、《中华人民 共和国证券法》《湖北华强科技股份有限公司章程》《湖北华强科技股份有限公司 董事会议事规则》等有关法律、法规、规范性文件的规定，会议决议合法、有效。 二、董事会会议审议情况 经与会董事审议，做出以下决议： （一）审议通过《关于变更持续督导保荐机构和保荐代表人的议案》 公司董事会同意《关于变更持续督导保荐机构和保荐代表人的议案》，并授 权 ...

Group 1 - The military equipment restructuring concept declined by 1.49%, ranking among the top declines in the concept sector, with companies like Zhongguangxue, Huachuang Technology, and Hunan Tianyan experiencing significant drops [1][2] - Among the stocks in the military equipment restructuring concept, only two stocks saw price increases, with Changcheng Military Industry and Changan Automobile rising by 3.04% and 0.08% respectively [1][2] - The military equipment restructuring concept experienced a net outflow of 554 million yuan from main funds today, with six stocks seeing net outflows, and five stocks having outflows exceeding 10 million yuan [2] Group 2 - Hunan Tianyan had the highest net outflow of main funds at 262 million yuan, followed by Changcheng Military Industry, Huachuang Technology, and Zhongguangxue with net outflows of 155 million yuan, 52.29 million yuan, and 50.06 million yuan respectively [2] - The trading volume for Hunan Tianyan was 24.89%, while Changcheng Military Industry had a trading volume of 17.18% [2] - The military equipment restructuring concept saw a mix of performance, with some stocks like Changan Automobile showing slight gains despite the overall decline in the sector [1][2]

New Stock Issuance - The new stock "同宇新材" (code: 301630) is listed at an issuance price of 84.00[1] - "信通电子" (code: 001388) has an issuance price of 16.42[1] Rights Issues and Announcements - "济川药业" (code: 600566) has a tender offer period from June 18, 2025, to July 17, 2025[1] - "中程退" (code: 300208) has 13 trading days remaining until the last trading day[1] - "退市锦港" (code: 600190) also has 13 trading days remaining until the last trading day[1] - "恒立退" (code: 000622) has 10 trading days remaining until the last trading day[1] Abnormal Fluctuations - "浙江东日" (code: 600113) reported severe abnormal fluctuations[1] - "汇金股份" (code: 300368) is noted for abnormal fluctuations[3]

Investment Rating - The report maintains a "Recommended" investment rating for the healthcare sector [7]. Core Insights - The healthcare sector has shown a mixed performance, with the Shenyin Wanguo Pharmaceutical Bio Index rising by 1.60% from June 23 to June 27, 2025, underperforming the CSI 300 Index by 0.35 percentage points [2][12]. - Year-to-date, the pharmaceutical sector has increased by 6.24%, outperforming the CSI 300 Index by 6.57 percentage points, ranking 11th among 31 sectors [2][14]. - As of June 27, 2025, the valuation of the pharmaceutical sector stands at 27.54 times (TTM overall method, excluding negative values), with a premium of 140.94% compared to the CSI 300 [2][17]. Summary by Sections 1. Market Performance - The pharmaceutical sector's performance from June 23 to June 27, 2025, was a 1.60% increase, ranking 23rd among 31 sectors [12]. - The year-to-date performance shows a 6.24% increase, ranking 11th among 31 sectors [14]. 2. Important Events - The National Healthcare Security Administration released the "2025 Basic Medical Insurance Directory and Commercial Insurance Innovative Drug Directory Adjustment Application Guidelines," marking a significant step for commercial health insurance in the multi-level medical security system [4][21]. 3. Industry Perspective - The inclusion of the commercial insurance innovative drug directory indicates an enhanced role for commercial insurance in the multi-level medical security system, providing greater opportunities for the industry [5][22]. - The report expresses optimism for innovative drugs, overseas expansion, and the clearing of procurement in specific segments, suggesting a focus on companies involved in these areas [22].

Group 1 - The closing price of Huachuang Technology (688151) on June 30 was 28.19 yuan, representing a 17.17% increase, with a turnover rate of 7.80% and an amplitude of 19.25%, resulting in a transaction volume of 715 million yuan [2] - The stock was listed on the daily trading list due to its closing price increase of 15% [2] - The top five trading departments accounted for a total transaction of 84.55 million yuan, with a net sell of 17.58 million yuan [2] Group 2 - The main capital inflow for the stock was 38.99 million yuan throughout the day [3] - The largest buying department was Goldman Sachs (China) Securities, with a purchase amount of 8.58 million yuan, followed by Guosen Securities with 6.94 million yuan [3] - The largest selling department was Guojin Securities, with a selling amount of 12.98 million yuan [3]